The Wyss Institute at Harvard University is a research and development engine for disruptive innovation powered by bioinspired technologies with visionary people at its heart.
Our mission is to transform healthcare and the environment by developing innovative technologies that emulate the way Nature builds, and accelerate their translation into commercial products through the formation of startups and corporate partnerships to bring about positive near-term impact in the world.
Our unique model of technology translation breaks down the traditional silos of academia and barriers with industry, enabling our world-leading visionary faculty to collaborate creatively across our focus areas of diagnostics, therapeutics, medtech, and sustainability.
Since our founding in 2009, we have demonstrated our ability to generate a pipeline of groundbreaking ideas and invent breakthrough technologies that address global challenges in healthcare and the environment through interdisciplinary collaboration, both within Harvard and through partnerships with leading institutions in the Boston/Cambridge ecosystem and around the world.
Our Wyss Community Values represent the ideals that we as an Institute hope to embody and foster across all levels of our organization and were decided upon collectively through extensive input from all team members. We excel in embodying some of these values, while others represent our aspirations, illustrating the ideal work culture we aim to achieve and are actively working towards.
- publications 0
- patent filings 0
- licenses 0
- startups 0
Our technologies are developed through strategic partnerships with industry, government, foundations, investors and philanthropists, and they are rapidly brought to the marketplace through licensing agreements and the creation of new startups. By harnessing the ingenuity of our 12 Core and 14 Associate Faculty, the Wyss Institute enables a significant portion of all intellectual property and startups that emerge from Harvard annually, with more than 1,394 issued patents, 130 licensing agreements, and 58 startups launched since our inception.